Arblet: Developed Vital Data Acquisition / Analysis Platform [BRIDGE Tokyo Nominated Company Introduction] | BRIDGE Technology & Startup Information

Arblet: Developed Vital Data Acquisition / Analysis Platform [BRIDGE Tokyo Nominated Company Introduction] | BRIDGE Technology & Startup Information

This article introduces the plans of BRIDGE Tokyo. At the online event to be held from January 19th, we will deliver a session inviting top runner entrepreneurs under the theme of "Digital Democratization Realized by NEXT Startups". We are currently distributing a limited number of free viewing tickets, so please check them out as soon as possible.

Prior to the "BRIDGE Tokyo 2022" scheduled to be held from January 19, BRIDGE announced 106 companies nominated for the "INTRO Showcase" list, which celebrates the next generation of startups.

These 106 companies have been selected by the venture capital (VC) and corporate venture capital (CVC) who cooperate with BRIDGE Tokyo 2022 as "young capitalists" who support the next generation of corporate growth. This is a list of candidates from the perspective.

The 106 companies listed are the companies that have accepted the nominations from the selected candidates. The criteria for nominations is that the company was founded after 2015 and is a fast-growing company that may be listed within about five years.

BRIDGE will introduce 106 companies (in no particular order) for the final selection announced on January 28, the final day of his BRIDGE Tokyo 2022. Interview articles will also be posted for companies that attracted attention in the final selection.

Arblet digitizes and connects "states of human life" that medical care could not intervene in the past. The wrist-worn wearable terminal developed in-house is equipped with an advanced semiconductor sensor, and the sensor data is transmitted to the cloud as it is via an edge terminal such as a smartphone, and the basic configuration for data processing and data storage using analysis algorithms on the cloud. It has become.

Arblet:バイタルデータの取得・解析プラットフォームを開発【BRIDGE Tokyoノミネート企業紹介】 | BRIDGE(ブリッジ)テクノロジー&スタートアップ情報

With this mechanism, it is possible to fully utilize the signal information discarded by many existing wearable terminals, and it is possible to calculate vital fluctuations and behavior information of consumers at the same time. There is a possibility of catching physical and mental stress and signs of illness that consumers have not noticed before.

By linking the sensing data accumulated by Arblet with various past research results, it is possible to develop a service that provides future risk predictions and alerts not only to consumers with health anxiety but also to healthy consumers. I think.

Nobuhito Muroi (FGN ABBALab)

We are developing Japan's first wearable device that can constantly measure blood pressure without pressure on the arm. Can it be measured with an Apple Watch or other wearables? Many people think that, but in fact, blood pressure monitors that can constantly measure blood pressure without pressure are not available in Japan.

His Arblet succeeded in raising this to an accuracy that can be implemented in the medical field with a unique algorithm. It is said that one-third of Japanese people have high blood pressure, and blood pressure is a region that is attracting attention because it is in high demand as wearable data to be sensed.

BRIDGE operates a membership system "BRIDGE Members". The member community "BRIDGE Tokyo" provides a place where startups and readers can connect through tech news, trend information summarization, Discord, events, and so on. Registration is free.
Free member registration